MRI评估开放骺板骨肉瘤的经骺板切除:16例回顾性研究
该研究回顾性分析16例(男7例、女9例,平均年龄12.2岁(7-16岁))开放骺板膝关节骨肉瘤患者,采用经骺板切除(TER)保肢治疗,通过新辅助化疗前后MRI评估肿瘤范围及对化疗的反应。结果显示术后病理切缘均为阴性,末次随访时12例持续无病、3例无疾病证据、1例死于疾病;保留同种异体骨或回收自体骨的患者平均膝关节屈曲范围126°(90°-150°),平均肌肉骨骼肿瘤学会功能评分27.6(23-30)。结论认为,当MRI确认化疗反应良好且肿瘤未进展至骨骺时,TER是开放骺板儿童及年轻骨肉瘤患者有效的保肢技术。
要点
- TER适用于开放骺板、化疗反应良好且MRI确认肿瘤未进展至骨骺的膝关节骨肉瘤患者。
- 16例患者术后病理切缘均为阴性,末次随访15例无病存活、1例死于疾病。
- 保留移植物患者平均膝关节屈曲126°(90°-150°),MSTS功能评分平均27.6(23-30)。
核心结论
- TER是治疗开放骺板儿童及年轻骨肉瘤患者干骺端恶性骨肿瘤的有效保肢技术,前提是MRI确认化疗反应良好且肿瘤未进展至骨骺。
研究设计与样本
- 回顾性研究,纳入16例(男7例、女9例,平均年龄12.2岁(7-16岁))膝关节骨肉瘤并接受TER治疗的患者。
- 评估所有患者新辅助化疗前后的MRI以判断病变范围及治疗反应,并回顾肿瘤学与功能结局;平均随访64.3个月(25-148),无失访。
主要发现
- 新辅助化疗前MRI显示13例肿瘤靠近但未接触骺板、3例部分接触骺板,8例存在骨骺骨髓水肿。
- 新辅助化疗后所有患者骨骺骨髓水肿消失,11例肿瘤未接触骺板、5例部分接触骺板。
- 术后病理切缘均为阴性;末次随访12例持续无病、3例无疾病证据、1例死于疾病。
- 保留同种异体骨或回收自体骨的患者平均膝关节屈曲范围126°(90°-150°),平均MSTS功能评分27.6(23-30)。
关键数值与推荐
- MRI评估显示新辅助化疗后骨骺骨髓水肿均消失,肿瘤与骺板关系由化疗前13例未接触/3例部分接触变为11例未接触/5例部分接触。
- 术后病理切缘阴性为16例全部患者。
- 功能评估采用膝关节屈曲范围和MSTS评分,平均屈曲126°(90°-150°),平均MSTS评分27.6(23-30)。
临床怎么用
- 对开放骺板的儿童及年轻膝关节骨肉瘤患者,可通过新辅助化疗前后MRI评估肿瘤与骺板关系及化疗反应,筛选适合TER的病例。
- TER可实现保肢并保留生理关节,术后病理切缘阴性及可接受的膝关节功能支持其临床应用。
局限性
- 本研究为回顾性设计,样本量16例,平均随访64.3个月(25-148),缺乏对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: For paediatric and adolescent patients with growth potential, preservation of the physiological joint by transepiphyseal resection (TER) of the femur confers definite advantages over arthroplasty procedures. We hypothesized that the extent of the tumour and changes in its extent after neoadjuvant chemotherapy are essential factors in the selection of this procedure, and can be assessed with MRI. The oncological and functional outcomes of the procedure were reviewed to confirm its safety and efficacy. METHODS: We retrospectively reviewed 16 patients (seven male and nine female, mean age 12.2 years (7 to 16)) with osteosarcoma of the knee who had been treated by TER. We evaluated the MRI scans before and after neoadjuvant chemotherapy for all patients to assess the extent of the disease and the response to treatment. RESULTS: The mean follow-up period was 64.3 months (25 to 148) after surgery and no patients were lost to follow-up. On MRI evaluation, 13 tumours were near but not in contact with the physes and three tumours were partially in contact with the physes before neoadjuvant chemotherapy. Bone oedema in the epiphysis was observed in eight patients. After neoadjuvant chemotherapy, bone oedema in the epiphysis disappeared in all patients. In total, 11 tumours were not in contact and five tumours were in partial contact with the physes. The postoperative pathological margin was negative in all patients. At the last follow-up, 12 patients were continuously disease-free and three had no evidence of disease. One patient died due to the disease. Functionally, the patients with retained allograft or recycled autograft had a mean knee range of flexion of 126° (90° to 150°). The mean Musculoskeletal Tumor Society functional score was 27.6 (23 to 30). CONCLUSION: TER is an effective limb-salvage technique for treating malignant metaphyseal bone tumours in paediatric and young osteosarcoma patients with open physes when a good response to chemotherapy and no progression of the tumour to the epiphysis have been confirmed by MRI. Cite this article: Bone Joint J 2020;102-B(6):772-778.
引用
- Kim Y, Jang WY, Park JW, et al. Transepiphyseal resection for osteosarcoma in patients with open physes using MRI assessment. Bone Joint J. 2020. PMID: 32475249. doi:10.1302/0301-620X.102B6.BJJ-2019-1141.R2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。